Large U.S. Buyers Turn to Eevia Amid Tariff Driven Supply Chain Uncertainty
Eevia Health Plc is experiencing a sharp spike in requests for prices and products as ripple effects from the U.S. imposed China tariffs, which now disrupt global nutraceutical supply chains. Several major U.S.-based companies are urgently seeking alternative sources for compendial plant-based ingredients—especially low-concentrate powders—to mitigate the risk of stockouts and margin pressure caused by […]
Read more...